Efficacy and tolerability of oral sumatriptan in the treatment of acute migraine.
An open prospective study of the efficacy and tolerability of oral sumatriptan in the treatment of acute migraine attacks at the Kenyatta National Hospital, Nairobi, Kenya, is presented. Thirty two patients were initially recruited and 24 completed the trial giving a drop-out rate of 25%. The age range was 17 to 55 years with a mean of 35 years. Sumatriptan was found to be effective in 22 (92%) out of 24 patients. Side effects occurred in 38% (9/24) patients. These were mild and transient and included nausea, vomiting, numbness of limbs, fever and a feeling of heat in the head. It is concluded that oral sumatriptan is an effective drug in the treatment of acute migraine headaches. It has few side effects and is well tolerated by majority of patients.
Kwasa
T O
TO
Kenyatta National Hospital, Nairobi, Kenya.
Jowi
J O
JO
Amayo
E O
EO
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010352:Patient Dropouts; D018170:Sumatriptan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D018170:Sumatriptan